Close
Story
Promising compound kills range of hard-to-treat cancers
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
Search result for "Solr search content"
Search Result for "Breast Cancer"
provider
Brian Fricke, MD Physical Medicine, Cancer Rehabilitation
Clinical Trial
S2206, Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) plus Chemotherapy versus Chemotherapy Alone for Adults with MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Bre
This clinical trial aims to validate the results observed in I-SPY2 and will test if adding durvalumab to neoadjuvant chemotherapy can increase pCR rates, shift residual cancer burden to lower values and improve invasive breast cancer free survival in early-stage HRpositive MP2 cancers.
Cancer Type
Uterine Cancer
Cancer Type
Brain Cancer
Cancer Type
Non-Hodgkin Lymphoma
Story
The role of genetic testing in cancer prevention and treatment
Discover how genetic testing at the Mays Cancer Center can guide cancer prevention and treatment. Learn about DNA analysis, personalized risk management, and family implications, as our expert counselors support your journey to proactive, informed cancer care.
Oct
30
Story
Siblings in remission race to honor everyday cancer heroes – and each other
More than $80,000 was raised during this year's Give Cancer the Boot Survivorship 5K and 1-Mile Walk to support cancer patients and their families. For survivors, the race was about something more personal: celebrating life, one step at a time.
Story
Meet the Mays Cancer Center's newest providers
We're thrilled to introduce four exceptional new doctors to our cancer center team! Their broad expertise and dedication make them ready to provide top-notch care and innovative treatments. Read to learn more about their impressive backgrounds and how they'll enhance our patient services.